Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NVUSPH · Entity 379 | Director | May 19, 2026 | May 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
U S PHYSICAL THERAPY INC /NV
Report date May 19, 2026 · Filed May 28, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,092 |
Reported balance
After 2026-05-19 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 2,306 · Balance 27,092 F1: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61. F2: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates. |
Filing footnotes · ownership attribution and instrument terms
F1: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61.
F2: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 20, 2026 20:08 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 2,306 | $61.61 | $142,072.66 |
DisclosureSEC source: 0001193125-26-232573 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,092 F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 28, 2026 20:08 UTC Amendment | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 2,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245224 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,092 F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61. F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:09 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 4,000 | $69.00 | $276,000.00 |
DisclosureSEC source: 0001193125-25-293697 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,786 F1 · balance_after: Includes 471 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. These shares will fully vest on March 6, 2026 if she remains as a member of the Board of Directors of the Company on that date. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075778 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,786 F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:38 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 2,000 | $86.09 | $172,180.00 |
DisclosureSEC source: 0000950170-24-103046 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,904 F1 · price: The price reported $86.09 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $85.93 to $86.17 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 1,068 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 356 shares on October 1, 2024, January 1, 2025 and April 1, 2025, if she is a member of the Board of Directors of the Company on those dates. Read SEC document |
| May 20, 2024 Filed May 21, 2024 22:34 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,424 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-063172 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,904 F1 · shares: Includes 1,424 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 356 shares on July 1, 2024, October 1, 2024, January 1, 2025 and April 1, 2025, if he is a director of the Company on those dates. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 00:09 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 1,000 | $82.34 | $82,340.00 |
DisclosureSEC source: 0001209191-23-055080 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,480 F1 · price: The price reported is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $82.32 to $82.35 per share both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of it shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 800 shares of restricted stock granted under the Company equity plans. Restrictions lapse as to 400 shares lapsed on each of January 1, 2024 and April 1, 2023, if she is a director of the Company on those dates. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030619 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,480 F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2023, if she is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 15:09 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 1,000 | $81.71 | $81,710.00 |
DisclosureSEC source: 0001209191-22-047678 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,880 F1 · price: The price reported is a weighted average price $81.71. The shares were purchased in multiple transactions at prices ranging from $81.45 to $81.79 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 1,200 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of October 1, 2022, January 1, 2023, and April 1, 2023, if she is a director of the Company on those dates. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 15:55 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 600 | $92.26 | $55,356.00 |
DisclosureSEC source: 0001209191-22-044937 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,880 F1 · price: The price reported is a weighted average price $92.26. The shares were purchased in multiple transactions at prices ranging from $92.25 to $92.32 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 1,200 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of October 1, 2022, January 1, 2023, and April 1, 2023, if she is a director of the Company on those dates. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:26 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030040 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,280 F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2022, October 1, 2022, January 1, 2023 and April 1, 2023, if she is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 19:36 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 1,000 | $94.21 | $94,210.00 |
DisclosureSEC source: 0001209191-21-068491 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,680 F1 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $94.08 to $94.29, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 740 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of January 1, 2022 and April 1, 2022, if she is a director of the Company on those dates. Read SEC document |
| May 20, 2021 Filed May 21, 2021 14:37 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 1,000 | $116.67 | $116,670.00 |
DisclosureSEC source: 0001209191-21-034778 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,680 F1 · price: The price reported is a weighted average price ($116.67). The shares were purchased in multiple transactions at prices ranging from $116.44 to, and including, $116.93 per share. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if she is a director of the Company on those dates. Read SEC document |
| May 17, 2021 Filed May 19, 2021 15:27 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033889 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,680 F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if she is a director of the Company on those dates. F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 13:34 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047417 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,200 F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse for 400 shares upon grant and 400 shares on each of October 1, 2020 and January 1 and April 1, 2021, if she is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares noted in above footnote. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 15:17 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 500 | $114.00 | $57,000.00 |
DisclosureSEC source: 0001209191-19-059414 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,600 F1 · balance_after: Includes 800 shares of common stock that was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on January 1, 2020 and April 1, 2020, if she is a director of the Company on those dates. Read SEC document |
| May 20, 2019 Filed May 22, 2019 19:01 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031985 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,100 F1 · shares: The 1,600 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020, if she is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares discussed in Note 1. Read SEC document |
| March 29, 2019 Filed Apr 1, 2019 15:06 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 500 | $105.17 | $52,585.00 |
DisclosureSEC source: 0001209191-19-021902 · doc4.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.10 to $105.23, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.